Elsevier celebrates its 1,000th journal with the adoption of online submission and peer-review tool EES. The rollout has significantly reduced refereeing times and completed editorial processes by an average of 9 weeks. This development enhances the work of editors and reviewers, improving service for authors and readers.
A review of history and lessons from tobacco litigation inform the evaluation of potential litigation strategies against the food industry. The authors argue that public health lawsuits can encourage food companies to improve nutritional content and change marketing practices, ultimately addressing obesity issues.
The Journal of Endodontics, a peer-reviewed journal publishing scientific articles and case reports on pulp conservation and endodontic treatment, has been published by Elsevier since January 2006. The partnership aims to strengthen the journal's position as a vital resource for the worldwide dental community.
NeuroRx will be published quarterly by Elsevier and focuses on therapy of neurological disorders, providing a multidisciplinary perspective. Scheduled topics include Neuropsychiatry, Pediatric Neurotherapeutics, and Proteomics, Genomics, Metabolomics.
Researchers at institutions in developing countries can now access the scientific subset of the web using Scirus and TEK, reducing connectivity charges. The collaboration between Elsevier and MIT aims to provide a robust and user-friendly service to researchers globally.
A new approach to preventing SAD by starting antidepressant treatment in the fall has shown promise. Early intervention with bupropion-XL reduced the risk of fall-winter depression by 44% in patients with a history of recurring episodes.
The inaugural issue of Alzheimer's & Dementia focuses on the link between a high-folate diet and lower Alzheimer's disease risk, with studies showing a 55% reduction in risk for older adults. The journal will publish quarterly, offering valuable resources for professionals in the field.
A comprehensive study of mental disease in Europe found that 27% of the EU population experiences at least one mental disorder. The report highlights critical gaps in knowledge and under-treatment of mental disorders, emphasizing the need for coordinated research and better funding.
A study of 304 young adult users found that friends were the most important source of information about MDMA, followed by websites like DanceSafe.org. Younger and more educated users relied on the internet for information, while parents, mainstream media, and radio were considered less accurate sources.
Researchers analyzed over 13,000 live term births to assess the effect of medical abortion on subsequent pregnancy's birth weight. The study found that women who had undergone a medically induced abortion had lower rates of Low Birth Weight compared to those with no abortion history.
A recent study found that a new, experimental injectable sustained-release depot formulation of buprenorphine is safe and effective in treating narcotic addiction. The treatment provides long-term benefits, reducing opioid withdrawal symptoms and sensitivity to opioids.
A study published in Drug and Alcohol Dependence found that oral fluid testing is as accurate as urinalysis in detecting opiate use. However, its effectiveness in detecting benzodiazepine use was significantly lower. The ease of administration makes it a promising alternative for treatment settings.
Simulated driving performance was unaffected by opiate treatment, but impaired after alcohol consumption. The effects of alcohol in reducing performance were similar across all groups, challenging the need for restricted driving standards.
A new global study on HIV/AIDS indicates the effectiveness of needle and syringe exchange programmes for preventing HIV transmission among people who inject drugs. Distribution of sterile needles and syringes helps reduce HIV infection rates, with cities introducing exchanges seeing a 19% decrease in prevalence.
A study found that diuretic amiloride improved cerebral blood flow in cocaine-dependent subjects, reversing cognitive impairments and depressive symptoms. The medication's ability to dilate arteries in the brain may be responsible for this improvement.